Development and prospects for bispecific antibody-based therapeutics in cancer and other applications

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.3, Iss.9, 2008-09, pp. : 1081-1097

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibody-based cancer therapy

By Baxevanis Constantin N

Expert Opinion on Drug Discovery, Vol. 3, Iss. 4, 2008-04 ,pp. : 441-452

Informa Healthcare

Access to resources Recommend Favorite

Antibody-based antiangiogenic cancer therapy

By Sanz Laura Álvarez-Vallina Luis

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 6, 2005-12 ,pp. : 1235-1245

Informa Healthcare

Access to resources Recommend Favorite

ED-B fibronectin as a target for antibody-based cancer treatments

By Menrad Andreas Menssen Hans D

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 491-500

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal Antibody-Based Therapy Strategies: Providing Options for the Cancer Patient

Current Pharmaceutical Design, Vol. 8, Iss. 19, 2002-09 ,pp. : 1749-1764

Bentham Science Publishers

Access to resources Recommend Favorite

Phytocannabinoids for Cancer Therapeutics: Recent Updates and Future Prospects

Current Medicinal Chemistry, Vol. 22, Iss. 30, 2015-01 ,pp. : 3472-3501

Bentham Science Publishers

Access to resources Recommend Favorite